| Uterine Artery Occlusion for Fibroid Related Bleeding (NCT00496067) | Ethicon, Inc. | 2007-04-01 |
| Mifepristone for Treatment of Uterine Fibroids (NCT00712595) | Mediterranea Medica S. L. | 2007-01-01 |
| MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication (NCT00365989) | InSightec | 2006-10-01 |
| Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 (NCT00958334) | Repros Therapeutics Inc. | 2006-09-07 |
| A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. (NCT00776074) | Takeda | 2006-06-01 |
| Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids (NCT00882258) | Repros Therapeutics Inc. | 2006-03-01 |
| MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation (NCT00295217) | InSightec | 2006-02-01 |
| A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) (NCT00628901) | Boston Scientific Corporation | 2006-01-01 |
| Uterine Fibroid Pregnancy Registry (NCT00232713) | Syneos Health | 2005-12-01 |
| MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids (NCT00166270) | InSightec | 2005-01-01 |
| Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata (NCT00163930) | Bayside Health | 2005-01-01 |
| The Effect of Mifepristone on Uterine Fibroids and Breast Tissue (NCT00579475) | Karolinska Institutet | 2004-11-01 |
| Study of Asoprisnil in the Treatment of Uterine Fibroids. (NCT00156156) | Abbott | 2004-11-01 |
| Safety of Treatment of Uterine Fibroids With Asoprisnil (NCT00156208) | Abbott | 2004-04-01 |
| Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future (NCT00180739) | Imperial College London | 2004-04-01 |
| Radiofrequency Ablation of Uterine Fibroids (NCT00584207) | University of California, Davis | 2004-03-01 |
| A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids (NCT00152256) | Abbott | 2003-09-01 |
| A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy (NCT00150644) | Abbott | 2003-07-01 |
| Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids (NCT00159328) | Imperial College London | 2003-03-01 |
| Women's Use of Alternative Medicine: A Multiethnic Study (NCT00067249) | National Center for Complementary and Integrative Health (NCCIH) | 2001-04-01 |
| Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine Fibroids (NCT00277680) | Ullevaal University Hospital | 2000-12-01 |
| Risk Factors for Uterine Fibroids: A Case Control Study (NCT00339547) | National Institute of Environmental Health Sciences (NIEHS) | 1995-11-01 |
| Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms (NCT00874302) | Repros Therapeutics Inc. | |
| Uterine Artery Embolization for Symptomatic Fibroids (NCT00354471) | University of Manitoba | |